Yukari Okubo

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

Kristian Reich, Kim Papp, Andrew Blauvelt et al. · The Lancet · 2021 · 297 citations

Medicine, Dermatology, Pharmacology +9

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

Bruce Strober, Caitriona Ryan, Peter van de Kerkhof et al. · Journal of the American Academy of Dermatology · 2019 · 243 citations · Full text

Medicine, Dermatology, Dermatopathology +9

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase <scp>III</scp> open‐label multicenter Japanese study

Shinichi Imafuku, Masaru Honma, Yukari Okubo et al. · The Journal of Dermatology · 2016 · 187 citations

Medicine, Dermatology, Pharmacotherapy +13

Music Therapy Using Singing Training Improves Psychomotor Speed in Patients with Alzheimer's Disease: A Neuropsychological and fMRI Study

Masayuki Satoh, Toru Yuba, Ken‐ichi Tabei et al. · Dementia and Geriatric Cognitive Disorders Extra · 2015 · 107 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Efficacy and Safety of Guselkumab, an Anti–interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis

Tadashi Terui, Satomi Kobayashi, Yukari Okubo et al. · JAMA Dermatology · 2018 · 107 citations · Full text

Medicine, Dermatology, Immunology +17